Cecilia J Hillard1. 1. Neuroscience Research Center, and Department of Pharmacology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Electronic address: chillard@mcw.edu.
Abstract
The purpose of this chapter is to provide an introduction to the mechanisms for the regulation of endocannabinoid signaling through CB1 cannabinoid receptors in the central nervous system. The processes involved in the synthesis and degradation of the two most well-studied endocannabinoids, 2-arachidonoylglycerol and N-arachidonylethanolamine are outlined along with information regarding the regulation of the proteins involved. Signaling mechanisms and pharmacology of the CB1 cannabinoid receptor are outlined, as is the paradigm of endocannabinoid/CB1 receptor regulation of neurotransmitter release. The reader is encouraged to appreciate the importance of the endocannabinoid/CB1 receptor signaling system in the regulation of synaptic activity in the brain.
The purpose of this chapter is to provide an introduction to the mechanisms for the regulation of endocannabinoid signaling through n class="Gene">CB1 cannabinoid receptors in the central nervous system. The processes involved in the synthesis and degradation of the two most well-studied endocannabinoids, 2-arachidonoylglycerol and N-arachidonylethanolamine are outlined along with information regarding the regulation of the proteins involved. Signaling mechanisms and pharmacology of the CB1 cannabinoid receptor are outlined, as is the paradigm of endocannabinoid/CB1 receptor regulation of neurotransmitter release. The reader is encouraged to appreciate the importance of the endocannabinoid/CB1 receptor signaling system in the regulation of synaptic activity in the brain.
Authors: Martin R Price; Gemma L Baillie; Adèle Thomas; Lesley A Stevenson; Morag Easson; Richard Goodwin; Adèle McLean; Lorraine McIntosh; Gillian Goodwin; Glenn Walker; Paul Westwood; Julia Marrs; Fiona Thomson; Phillip Cowley; Arthur Christopoulos; Roger G Pertwee; Ruth A Ross Journal: Mol Pharmacol Date: 2005-08-19 Impact factor: 4.436
Authors: Stefan Engeli; Anne-Christin Lehmann; Jana Kaminski; Verena Haas; Jürgen Janke; Alexander A Zoerner; Friedrich C Luft; Dimitrios Tsikas; Jens Jordan Journal: Obesity (Silver Spring) Date: 2014-03-11 Impact factor: 5.002
Authors: L Hanus; S Abu-Lafi; E Fride; A Breuer; Z Vogel; D E Shalev; I Kustanovich; R Mechoulam Journal: Proc Natl Acad Sci U S A Date: 2001-03-20 Impact factor: 11.205
Authors: C J Hillard; S Manna; M J Greenberg; R DiCamelli; R A Ross; L A Stevenson; V Murphy; R G Pertwee; W B Campbell Journal: J Pharmacol Exp Ther Date: 1999-06 Impact factor: 4.030
Authors: Dina Navia-Paldanius; Niina Aaltonen; Marko Lehtonen; Juha R Savinainen; Ulrike Taschler; Franz P W Radner; Robert Zimmermann; Jarmo T Laitinen Journal: Eur J Pharm Sci Date: 2015-06-09 Impact factor: 4.384
Authors: Tiziana Bisogno; Maria Grazia Cascio; Bijali Saha; Anu Mahadevan; Paolo Urbani; Alberto Minassi; Giovanni Appendino; Carmela Saturnino; Billy Martin; Raj Razdan; Vincenzo Di Marzo Journal: Biochim Biophys Acta Date: 2006-01-23
Authors: Cecilia J Hillard; Huan Huang; Caleb D Vogt; Beatriz E Rodrigues; Terrence S Neumann; Daniel S Sem; Friedhelm Schroeder; Christopher W Cunningham Journal: Methods Enzymol Date: 2017-07-17 Impact factor: 1.600
Authors: Angelique G Brellenthin; Kevin M Crombie; Cecilia J Hillard; Randall T Brown; Kelli F Koltyn Journal: Subst Abus Date: 2019-11-15 Impact factor: 3.716